Haemonetics is trading 4.2% up at $79.92 as the stock moves in tandem with a broad healthcare sector rally.
- The upward momentum is driven by strong earnings from UnitedHealth and positive news from other large-cap healthcare names, lifting the overall sector.
- There are no fresh, stock-specific headlines or earnings reports for Haemonetics today, suggesting the price action is primarily sector-driven.
- The move comes as investors rotate into healthcare stocks amid mixed performance across the broader markets.